Represented Dicerna in trade secret litigation regarding RNA interference technology. Settled before trial favorably for Dicerna.
Dicerna Pharms, Inc. v. Alnylam Pharms, Inc. (17-11466) (D. Mass)
Represented Dicerna in antitrust litigation with its competitor Alnylam in the RNA interference field. Settled favorably for Dicerna.
Almirall, LLC v. Acrux DDS Pty. Ltd. (2:2021-cv-11948) (D. NJ)
Representing Defendant Acrux in patent litigation over ANDA to make a generic version of Almirall’s topical acne product Aczone (dapsone). Pending.